Valproic Acid and Levetiracetam Together: What FDA Data Tells Us About This Seizure Drug Combination

Maria, a 48-year-old with a 15-year history of generalized seizures, has been stable on valproic acid for over a decade. Last month, her neurologist added levetiracetam to her regimen after her seizures began breaking through her existing therapy. Three weeks into the combination, Maria noticed she was unusually drowsy, her hands trembled more than usual, and she felt foggy during conversations with her family. She wondered: Is this normal? Are these two seizure medications safe to take together? And should she be concerned?

Questions like Maria's are common—and important. When two anticonvulsant drugs are prescribed together, patients deserve clear, evidence-based information about what to expect and when to seek help. While no specific contraindication exists between valproic acid and levetiracetam in FDA drug labeling, understanding what each drug does, what the FDA labels reveal, and how to monitor for adverse effects is essential for safe medication use.

Overview: Two Different Seizure Medications, One Important Question

Valproic acid (also called divalproex or depakote) and levetiracetam (Keppra) are both anticonvulsant medications—but they work in different ways. Valproic acid has been used to prevent seizures for decades; it works by increasing levels of the neurotransmitter GABA in the brain, which calms nerve activity. Levetiracetam, approved by the FDA more recently, has a different mechanism: it binds to a specific brain protein (SV2A) involved in neurotransmitter release, making neurons less likely to fire uncontrollably.

Because they work through different pathways, neurologists sometimes combine them—a practice called polypharmacy—when a single drug isn't controlling seizures well enough. The question many patients ask: Does combining them create new risks?

What the FDA Says About Each Drug

According to FDA drug labeling for valproic acid, the most commonly documented adverse effects include drowsiness, tremor, hair loss, weight gain, and liver enzyme elevation. The FDA label also warns about serious but rare risks: pancreatitis, liver failure, and birth defects if used during pregnancy. These warnings reflect decades of real-world use and post-market safety monitoring through the FDA's Adverse Event Reporting System (FAERS).

The FDA label for levetiracetam lists similar central nervous system side effects: drowsiness, dizziness, headache, and coordination problems. It also flags behavioral changes—including mood swings, irritability, and in rare cases, suicidal thinking—which are important to monitor. Like valproic acid, levetiracetam can cause serious but uncommon events such as severe skin reactions.

Importantly, neither FDA label specifically identifies valproic acid as a contraindicated or major-risk interaction partner for levetiracetam, and vice versa. This does not mean the combination is risk-free—it means the FDA has not labeled a direct, predictable chemical interaction between these two drugs. However, the absence of a labeled interaction does not eliminate the need for careful monitoring.

Understanding the Real Risk: Additive Central Nervous System Effects

When two medications that both depress the central nervous system (CNS) are taken together, their effects can add up. Both valproic acid and levetiracetam list CNS depression—primarily drowsiness, dizziness, and impaired coordination—as common side effects. When combined, patients may experience additive CNS depression, meaning the drowsiness or cognitive fuzziness is more pronounced than either drug alone would cause.

This is not a chemical interaction in the traditional sense (where one drug blocks the metabolism of another). Instead, it is a pharmacodynamic effect: both drugs are acting on the same biological system (the brain) in ways that overlap. The result can be:

• Increased drowsiness or sedation
• Cognitive slowing or "brain fog"
• Impaired balance and coordination
• Difficulty concentrating or remembering things
• Increased risk of falls, especially in older adults

Maria's experience—the tremor, drowsiness, and foggy thinking—fits this pattern. While these effects often settle as the body adjusts to the combination, they deserve monitoring and should never be dismissed as unavoidable.

Severity and Risk Level: Who Needs to Worry Most

The combination of valproic acid and levetiracetam is not contraindicated (i.e., it is not absolutely forbidden by the FDA), but it carries a moderate risk for additive adverse effects that warrant careful supervision. The severity of risk depends on several factors:

• Age: Older adults metabolize both drugs more slowly and are more susceptible to CNS depression and fall risk.
• Baseline cognitive or motor function: Patients with existing tremor, balance problems, or memory concerns may notice changes more acutely.
• Dosing: Higher doses of either drug increase the likelihood and intensity of overlap effects.
• Other medications: If the patient is also taking other CNS depressants (opioids, benzodiazepines, alcohol), the risk escalates.
• Liver or kidney function: Both drugs are metabolized by the liver; impaired function can cause drug accumulation.

Who Is Most at Risk

Patients at higher risk for complications from this combination include those aged 65 and older, people with liver disease, those taking additional CNS depressants, pregnant women (due to birth defect risks with valproic acid), and individuals with a history of mood or behavioral problems (given levetiracetam's documented behavioral effects).

What You Should Do: Practical Steps for Safe Use

If you have been prescribed both valproic acid and levetiracetam, take these steps:

• Inform your pharmacist. Use the checkdruginteractions.com checker to review your full medication profile—not just these two drugs. Other medications may compound CNS effects.
• Ask about baseline expectations. Ask your neurologist or pharmacist what side effects are typical in the first 2–4 weeks and which are red flags.
• Start a simple side effect log. Note when drowsiness, tremor, or cognitive changes occur and how long they last. Share this with your doctor at your next visit.
• Avoid alcohol and other sedating substances. Even small amounts can amplify CNS depression.
• Be cautious with driving and machinery. Until you know how the combination affects you, avoid activities requiring sharp focus or quick reflexes.
• Take doses at consistent times. This helps your body establish a stable pattern and makes it easier to identify side effects.

When to Call Your Doctor

Contact your neurologist or primary care physician immediately if you experience:

• Severe drowsiness or inability to stay awake during the day
• Significant dizziness, loss of balance, or falls
• Confusion, memory loss, or difficulty thinking clearly
• Mood or behavioral changes (depression, anxiety, irritability, suicidal thoughts)
• Difficulty breathing or chest pain
• Jaundice (yellowing of skin or eyes), dark urine, or severe abdominal pain—signs of liver problems
• Rash, especially if it blisters or spreads

Do not wait for your next scheduled appointment if you experience any of these symptoms. These may signal a need to adjust doses, change the timing of doses, or switch one of the medications.

Bottom Line: Knowledge Is Your Best Safety Tool

Valproic acid and levetiracetam can often be used together safely and effectively, especially when seizure control is difficult to achieve with one drug alone. The FDA does not classify this as a major or contraindicated interaction. However, the potential for additive drowsiness, cognitive effects, and other overlapping side effects is real and deserves attention.

Your pharmacist and doctor are your best resources for monitoring this combination. Ask questions, report side effects honestly, and never assume that drowsiness or cognitive slowness is simply "part of living with seizures." Many side effects can be managed by adjusting timing, dose, or occasionally by substituting one medication for another.

Maria's tremor and foggy thinking led her to contact her neurologist. A simple dose adjustment—taking her levetiracetam in the evening instead of morning—made a significant difference. Her seizure control remained excellent, and her daytime alertness improved within a week. With knowledge, open communication, and careful monitoring, the combination worked for her.

Take Control of Your Medication Safety Today

Checking your full medication profile is fast, free, and risk-free. Whether you are taking two drugs, five drugs, or more, visit checkdruginteractions.com—the most comprehensive drug interaction checker on the internet—to verify that your complete medication list is safe. Our database contains over 250,000 FDA-labeled drug records and can check up to 20 drugs simultaneously. No account is needed, results are instant, and our autocomplete feature makes it easy to find every medication you take. Your safety is too important to leave to chance.